ScreenerHero
NXGNexgenRx Inc.
TSXV · CA · Healthcare · Health Information Services · nexgenrx.com
0.5500CAD-6.78%Mkt Cap: 28.49M $P/E: 27.50

NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. The company offers NexSys claims…

Industry Peers

Health Information Services
Screen all
VEE
Veeva System Inc. R
$38.07BUSDP/E 44.2
VEEV
Veeva Systems Inc Class A
$40.77BUSDP/E 44.6
BTSG
BrightSpring Health Services Inc. Common Stock
$11.74BUSDP/E 53.0
TEM
Tempus AI Inc. Class A Common Stock
$11.05BUSD
HQY
HealthEquity, Inc.
$8.71BUSDP/E 38.9
TXG
10x Genomics, Inc.
$8.10BUSD
HNGE
Hinge Health Inc. Class A Common Stock
$7.14BUSDP/E 10.8
WAY
Waystar Holding Corp. Common Stock
$4.76BUSDP/E 35.5
DOCS
Doximity, Inc.
$4.62BUSDP/E 30.9
HTFL
Heartflow Inc. Common Stock
$3.96BUSD
PRVA
Privia Health Group, Inc.
$2.75BUSDP/E 97.7
OMCL
Omnicell, Inc.
$1.66BUSDP/E 43.4
OMDA
Omada Health Inc. Common Stock
$1.50BUSDP/E 36.5
SDGR
Schrödinger, Inc.
$1.48BUSD
CERT
Certara, Inc.
$1.28BUSD
GDRX
GoodRx Holdings, Inc.
$1.21BUSDP/E 59.0
TDOC
Teladoc Health, Inc.
$1.18BUSD
TALK
Talkspace Inc. Common Stock
$870.57MUSD
HSTM
HealthStream, Inc.
$834.80MUSDP/E 39.7
PHR
Phreesia, Inc.
$738.82MUSDP/E 74.8

Key Statistics

Company
Market Cap28.49M $
Enterprise Value26.51M $
Revenue (TTM)13.44M $
Gross Profit10.88M $
Net Income (TTM)939.26K $
Revenue/Share0.1886 USD
Last Price0.5500 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)27.50
P/E (Forward)—
PEG6.53
EV/EBITDA12.55
EV/Revenue1.97
P/S2.12
P/B5.45
EPS (TTM)0.02
EPS (Forward)—
52W Range
0.290057% of range0.7500
52W High0.7500 CAD
52W Low0.2900 CAD
Profitability
Gross Margin83.28%
Oper. Margin24.99%
EBITDA Margin15.71%
Profit Margin7.19%
ROE16.92%
ROA3.52%
Growth
Revenue Growth11.60%
Earnings Growth166.70%
Cash Flow & Leverage
Operating CF3.62M $
CapEx (TTM)251.27K $
FCF Margin18.30%
FCF Yield8.64%
Net Debt-3.18M $
Net Debt/EBITDA-1.51
Balance Sheet
Debt/Equity0.05
Current Ratio1.16
Quick Ratio0.18
Book Value/Sh0.1010 CAD
Cash/Share0.0660 CAD
Dividends
Fwd Div Rate0.0100 CAD
Trail. Div Rate0.0000 CAD
Div. Yield1.69%
5Y Avg Yield—
Payout Ratio62.50%
Ex-Div DateApr 24, 2026
Pay DateApr 28, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.71.12M
Float44.81M
Insiders36.98%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short103
Short (prev mo.)416
Technical
SMA 500.5406 (+1.7%)
SMA 2000.4178 (+31.6%)
Beta0.52
S&P 52W Chg18.16%
Avg Vol (30d)40.11K
Avg Vol (10d)11.87K
Technical Indicators
RSI (14)46.9
MACD0.0212
MACD Signal0.0360
MACD Hist.-0.0148
BB Upper0.7273 CAD
BB Middle0.6035 CAD
BB Lower0.4797 CAD
BB Width41.04%
ATR (14)0.0296 CAD
Vol Ratio (20d)1.37x